Lupus Does Not Typically Cause True Flushing
Systemic lupus erythematosus (SLE) causes a fixed malar rash, not transient flushing. The characteristic "butterfly rash" of lupus is a persistent, erythematous eruption over the cheeks and nasal bridge that differs fundamentally from the episodic, transient facial flushing seen in conditions like carcinoid syndrome or rosacea 1.
Key Distinguishing Features
The Lupus Malar Rash:
- Fixed and persistent rather than coming and going in episodes
- Spares the nasolabial folds (a critical diagnostic feature)
- May be flat (macular) or raised (maculopapular)
- Often photosensitive and worsens with sun exposure
- Part of the diagnostic criteria for SLE 2, 3
True Flushing (NOT lupus):
- Episodic and transient, lasting minutes to hours
- Triggered by specific stimuli (alcohol, emotions, temperature changes)
- Involves the entire face including nasolabial folds
- Associated with conditions like carcinoid syndrome, rosacea, or medication reactions 1
Clinical Pitfall to Avoid
Do not confuse the persistent malar rash of lupus with transient flushing episodes. If a patient describes episodic facial redness that comes and goes, consider alternative diagnoses such as:
- Rosacea
- Carcinoid syndrome
- Medication-induced flushing
- Seborrheic dermatitis (which can affect malar prominences) 1
The malar rash in SLE may appear as a "transient rash before any other signs" 1, but this refers to it being an early manifestation of the disease, not that it comes and goes episodically like true flushing.
When Evaluating Facial Erythema in Suspected SLE
Look for the complete clinical picture that includes 2, 3:
- Constitutional symptoms (fever, fatigue)
- Other mucocutaneous manifestations (photosensitive rash, oral ulcers, alopecia)
- Musculoskeletal symptoms (arthralgia, myalgia)
- Positive autoantibodies (ANA, anti-dsDNA, anti-Sm)
- Low complement levels
- Evidence of other organ involvement
The 2019 EULAR/ACR classification criteria are 96.1% sensitive and 93.4% specific for SLE when these clinical and immunologic features are systematically evaluated 2.